POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $664,395 | -32.1% | 279,158 | -49.8% | 0.00% | – |
| Q2 2023 | $978,413 | -34.1% | 555,916 | +15.4% | 0.00% | – |
| Q1 2023 | $1,484,025 | +163.9% | 481,826 | +354.2% | 0.00% | – |
| Q4 2022 | $562,261 | +129.5% | 106,087 | +52.7% | 0.00% | – |
| Q3 2022 | $245,000 | +30.3% | 69,459 | -4.3% | 0.00% | – |
| Q2 2022 | $188,000 | -20.3% | 72,573 | +37.8% | 0.00% | – |
| Q1 2022 | $236,000 | -22.9% | 52,665 | +17.5% | 0.00% | – |
| Q4 2021 | $306,000 | +20.5% | 44,808 | +28.2% | 0.00% | – |
| Q3 2021 | $254,000 | +19.8% | 34,955 | +66.0% | 0.00% | – |
| Q2 2021 | $212,000 | +3433.3% | 21,062 | +3621.2% | 0.00% | – |
| Q1 2021 | $6,000 | -94.5% | 566 | -94.3% | 0.00% | – |
| Q4 2020 | $109,000 | +505.6% | 9,924 | +378.5% | 0.00% | – |
| Q3 2020 | $18,000 | – | 2,074 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |